Applications of PET in lung cancer

Seminars in Nuclear Medicine

Volumn 28, Issue 4, 1998, Pages 303-319

  Al Sugair, A ^a   Coleman, R E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; LUNG CANCER; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; REVIEW;

EID: 0031782650     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(98)80035-4     Document Type: Article

References (63)

1. Stanley K Stjernsward J Lung Cancer Hansen HH Basic and Clinical Concepts of Lung Cancer 1989 Kluwer Norwell, MA 4 11
2. Kurihara M Aoki K Hisamichi S Cancer Mortality Statistics in the World, 1950–1985 1989 University of Nagoya Press Nagoya, Japan
3. Magrath I Litvak J Cancer in developing countries: opportunity and challenge J Nat Cancer Instit 85 1993 862 873
4. Thomas P Rubinstein L The lung cancer study group: Cancer recurrence after resection: T1 N0 non-small cell lung cancer Ann Thorac Surg 49 1990 242 247
5. Boring CC Squires TS Tung T Cancer statistics—1992 CA 42 1992 19 43
6. Mack MJ Hazelrigg SR Landreneau RJ Acuft TE Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule Ann Thorac Surg 56 1993 825 832
7. Smith TAD FDG uptake, tumour characteristics, and response to therapy: a review Nucl Med Commun 19 1998 97 105
8. Ginsberg RS Vokes E Raben A Non-small cell cancer of the lung DeVita VT Hellman S Rosenberg SA Cancer Principles and Practice of Oncology 1997 Lippincott-Raven Philadelphia, PA 858 911
9. Lindholm P Mina H Leskinen Kallion S Influence of the blood glucose concentration on FDG uptake in cancer: a PET study J Nucl Med 34 1993 1 6
10. Hoh CK Hawkins RA Glaspy JA Cancer detection with whole-body positron emission tomography using flurodeoxyglucose J Comput Assist Tomogr 17 1993 582 589
11. Lowe VJ Hoffman JM DeLong DM Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities J Nucl Med 1994 1771 1776
12. 18F]fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
13. Lowe VJ DeLong DM Hoffman JM Coleman RE Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy J Nucl Med 36 1995 883 887
14. Wahl RL Quint LE Greenough RL Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation Radiology 191 1994 371 377
15. Lowe VJ Coleman RE Application of PET in oncology imaging Sandler MP Coleman RE Wackers FJ Th Diagnostic Nuclear Medicine Third Edition 1995 Williams and Wilkins Baltimore 1293 1308
16. Mori K Saitov Y Tominaga K Small nodular lesions in the lung periphery: new approach to diagnosis with CT Radiology 177 1990 843 849
17. Kuriyama K Tateishi R Doi O Prevalence of air bronchograms in small peripheral carcinomas of the lung on the thin-section CT: comparison with benign tumors AJR 156 1991 921 924
18. Kubota K Matsuzawa T Fujiwara T Differential diagnosis of lung tumor with positron emission tomography: A prospective study J Nucl Med 31 1990 1972
19. 961P Dehdashti F Griffeth LK McGuire AH FDG-PET evaluation of suspicious pulmonary and mediastinal masses J Nucl Med 32 1992
20. 18F] FDG PET in the monitoring and management of response to lung cancer therapy Radiology 185 1992
21. 139P Strauss LG Dimitrakopoulou AD Haberkorn U PET follow-up studies to evaluate tumor perfusion and metabolism in patients with small cell carcinoma of the lung Radiology 5 1992
22. Slosman DO Spiliopoulos A Couson F Satellite PET and lung cancer: A prospective study in surgical patients Nucl Med Comm 14 1993 955 961
23. 21P Knopp MV Bischoff H Ostertag H Clinical application of FDG-PET for staging of bronchogenic carcinoma J Nucl Med 34 1993
24. Khonsary SA Mandelkern MA Brown CV PET-FDG scanning in pulmonary mass lesions Clin Nucl Med 19 1993 922
25. 18F]-FDG positron emission tomography with surgical pathology Eur J Nucl Med 21 1994
26. Weber W Romer W Ziegler S Clinical value of F-18-FDG PET in solitary pulmonary nodules Eur J Nucl Med 22 1995 775
27. 18F-fluoro-deoxyglucose in the assessment of solitary pulmonary nodules Eur J Nucl Med 22 1995 775
28. Baum RP Rust M Strassmann O Whole-body positron emission tomography. FDG PET J Thorac Cardiovasc Surg 110 1995 130 140
29. Duhaylongsod FG Lowe VJ Patz EF Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography. FDG PET J Thorac Cardiovas Surg 110 1995 130 140
30. Hubner KF Buonocore E Singh SK Characterization of chest masses by FDG positron emission tomography Clin Nucl Med 20 1995 293 298
31. Dewan NA Reeb SD Gupta NC PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk.—benefit analysis Chest 108 1995 441 446
32. Gupta NC Maloof J Gunel E Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET J Nucl Med 37 1996 943 948
33. Lowe VJ Duhaylongsod FG Patz EF Pulmonary abnormalities and PET data analysis: A retrospective study Radiology 1997 435 439
34. Lowe VJ, Fletcher JW, Gobar L, et al: Prospective investigation of PET in lung nodules. J Clin Oncology (in press)
35. Conti PS Lilien DL Hawley K PET and [18F]-FDG in oncology: A clinical update Nucl Med Biol 23 1996 717 735
36. Duhaylongsod F Lowe VJ Patz EF Lung tumor growth correlates with glucose metabolism measured by FDG-PET Ann Thorac Surg 60 1995 1348 1352
37. Ahuja V, Coleman RE, Herndon J, Patz EF Jr: Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. J Clin Oncology (in press)
38. Webb WR Gatsonis C Zerhouni EA CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group Radiology 178 1991 705 713
39. Grimmel S Storck M Henrich M Diagnostic value of 18-F-FDG-PET in patients with lung cancer and lymph node metastases Eur J Nucl Med 20 1993 819
40. Buchpiguel CA Tse K Alavi A Use of quantitative FDG-PET whole-body imaging in staging lung cancer A comparison with CT Eur J Nucl Med 21 1994 S61
41. Patz EF Lowe VJ Goodman PC Thoracic nodal staging with PET imaging with 18 FDG in patients with bronchogenic carcinoma Chest 108 1994 1617 1621
42. 189S Sasaki M Ichiya Y Kuwabara Y The usefulness of FDG-PET for the detection of mediastinal lymph node metastases in patients with non-small-cell lung cancer: A comparative study with x-ray CT Eur J Nucl Med 21 1994
43. 18F]fluorodeoxyglucose Ann Thorac Surg 58 1994 698 703
44. Bury TH Paulus P Benoit TH Positron emission tomography versus computed tomography in the staging of mediastinal non-small-cell lung cancer Eur J Nucl Med 22 1995 846
45. 57P Madar I Hoh C Figlin RA Cost-effective staging of non-small-cell lung carcinoma by whole-body PET FDG imaging J Nucl Med 36 1995
46. Chin R Jr Ward R Keyes JW Jr Mediastinal staging of non-small-cell lung cancer with positron emission tomography Am J Resp Crit Care Med 152 1995 2090 2096
47. Valk PE Pounds TR Hopkins DM Staging lung cancer by PET imaging Ann Thorac Surg 60 1995 1573 1582
48. Sasaki M Ichiya Y Kuwabara Y The usefulness of positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with x-ray computed tomography Eur J Nucl Med 23 1996 741 747
49. Sazon DAD Santiago SM Soo GW Fluorodeoxy-glucose-positron emission tomography in the detection and staging of lung cancer Am J Respir Crit Care Med 153 1996 412 421
50. Engleman RM McNamara WL Bronchogenic carcinoma: a statistical review of two hundred twenty-four autopsies J Thorac Surg 27 1954 227 239
51. Erasmus JJ Patz EF McAdams HP Evaluation of adrenal masses in patients with bronchogenic carcinoma using FDG-PET imaging AJR 168 1997 1357 1360
52. Bury T Dowlate A Corhay JL Whole-body 18 FDG in the staging of non-small cell lung cancer Eur Respir J 10 1997 2529 2534
53. Lewis P Griffin S Marsden P Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer Lancet 344 1994 1265 1266
54. Hebert M Lowe V Hoffman J Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy Am J Clin Oncol 19 1996 416 421
55. Ichija Y Kuwabara Y Sasaki M A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann Nucl Med 10 1996 193 200
56. (abstract) Vansteenkiste J Stoobants S DeLyn P Prognostic significance of FDG-PET after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer (N2-NSCLC): analysis of 13 cases Proc Am Soc Clin Oncol 16 1998 75
57. Patz EF Jr Lowe VJ Hoffman JM Baine SS Harris LK Goodman PC Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[-18]-2-deoxy-D-glucose Radiology 191 1994 379 382
58. Inoue T Kim EE Komaki R Detecting recurrent or residual lung cancer with FDG-PET J Nucl Med 36 1995 788 793
59. Gambhir SS Hoh CG Phelps ME Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung carcinoma J Nucl Med 37 1996 1428 1436
60. Coleman RE Tesar RD Clinical PET: are we ready? J Nucl Med 38 1997 8N 9N
61. Coleman RE Camera-based PET: the best is yet to come J Nucl Med 38 1997 1796 1797
62. 108P Coleman RE Laymon CE Turkington TG Positron imaging of pulmonary nodules: phantom study (abstract) J Nucl Med 39 1998
63. (abstract) Delbeke D Sandler MP Al-Sugair A Comparison of dedicated and camera-based PET imaging of FDG in patients with focal pulmonary lesions J Nucl Med 39 1998 108P 109P